0000950123-23-007098.txt : 20230809
0000950123-23-007098.hdr.sgml : 20230809
20230809165500
ACCESSION NUMBER: 0000950123-23-007098
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230809
DATE AS OF CHANGE: 20230809
EFFECTIVENESS DATE: 20230809
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 231156014
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 1650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001560009
XXXXXXXX
06-30-2023
06-30-2023
false
Versant Venture Management, LLC
One Sansome Street, Suite 1650
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
000161130
802-75823
N
Max Eisenberg
Chief Operating Officer
(415) 801-8100
/s/ Max Eisenberg
San Francisco
CA
08-09-2023
0
8
84298028
false
INFORMATION TABLE
2
25287.xml
INFORMATION TABLE FOR FORM 13F
Adverum Biotechnologies, Inc.
Common Stock
00773U108
8058490
5068233
SH
OTR
0
5068233
0
Aligos Therapeutics, Inc.
Common Stock
01626L105
2253090
2320381
SH
OTR
0
2320381
0
CRISPR Therapeutics AG
Common Shares
H17182108
27989046
498558
SH
OTR
0
498558
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
5954095
543753
SH
OTR
0
543753
0
Gritstone Oncology, Inc.
Common Stock
39868T105
6944243
3561150
SH
OTR
0
3561150
0
Passage Bio, Inc.
Common Stock
702712100
4668631
4959769
SH
OTR
0
4959769
0
Repare Therapeutics, Inc.
Common Stock
760273102
28001631
2646657
SH
OTR
0
2646657
0
Minerva Surgical Inc.
Common Stock
60343F106
428802
1673700
SH
OTR
0
1673700
0